Naloxone-induced withdrawal in patients with buprenorphine dependence.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8173501.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Naloxone-induced withdrawal was studied in seven patients currently dependent only on injecting buprenorphine, within 3 to 6 hours of their last dose. Withdrawal severity began to rise from 5 minutes and reached a peak at 60 minutes after 1.2 mg naloxone given intravenously. The mean withdrawal severity score was significantly higher at 30, 60 and 90 minutes compared to the baseline. The most frequent withdrawal signs and symptoms were mydriasis, systolic hypertension, tachypnoea, muscle pains, yawning, anxiety, restlessness and craving.
Medical subject headings
- Buprenorphine
- Naloxone
- Opioid-Related Disorders
- Substance Abuse, Intravenous
- Substance Withdrawal Syndrome